News
22h
The Healthy @Reader's Digest on MSNDo GLP-1 Patches Work? An Expert Doctor Weighs In with the Verdict
Dr. Bhuyan serves on the boards of both Planned Parenthood Federation of America and Planned Parenthood Global. Her areas of ...
1d
MedPage Today on MSNNew Guideline Puts Some at the Front of the Line for GLP-1, SGLT2 Drugs
No blanket recommendation can be made for SGLT2 inhibitors and GLP-1 receptor agonists in adults with type 2 diabetes (T2D) ...
1d
Medpage Today on MSNGLP-1 Drugs May Hold Benefit in Painful Skin Disease
In this retrospective study, patients who started a GLP-1 agonist experienced significant declines in hidradenitis ...
GLP-1 receptor agonists like semaglutide and the dual GIP/GLP-1 agonist tirzepatide mimic naturally occurring hormones that regulate blood sugar, appetite, and digestion. GLP-1 (glucagon-like ...
One popular health platforms is promoting GLP-1 microdosing for weight loss: But how safe and effective is this approach?
Drugmaker Eli Lilly says their oral, daily GLP-1 pill, orforglipron, may offer similar weight loss results as weekly GLP-1 ...
GLP-1 medications like Ozempic and Zepbound are transforming chronic disease and weight management, with perimenopausal women ...
2d
MedPage Today on MSNGLP-1 Maker Accused of Bribing Docs; FDA Warns on Unapproved Meds; PFAS in Devices
The FDA said it's taking action to protect patients from unapproved animal-derived thyroid medications and expressed concern ...
For individuals with type 2 diabetes (T2D), glucagon-like peptide 1 receptor agonist (GLP-1 RA) use is associated with a slightly increased risk for incident diabetic retinopathy (DR) and with a ...
7h
News-Medical.Net on MSNGIPR signaling opens brain’s gate for GLP-1 weight-loss therapy
A Cell Metabolism study reveals that GIPR signaling in oligodendrocytes enhances brain access and weight-loss efficacy of GLP ...
In 2025, Släcka introduces a functional beverage designed to combat mid-afternoon cravings by offering a healthier ...
For older adults with type 2 diabetes, glucagon-like peptide-1 receptor agonist (GLP-1 RA) use is associated with nonarteritic anterior ischemic optic neuropathy (NAION).
Some results have been hidden because they may be inaccessible to you
Show inaccessible results